Laparoscopic Power Morcellators Market Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Laparoscopic Power Morcellators Market
A growing preference for minimally invasive surgical
techniques, as well as rising rates of uterine fibroids and endometriosis, were
the main drivers of the global market. Globally, more myomectomy and
hysterectomy surgeries are being performed, which will also aid in the expansion
of the laparoscopic power morcellators market.
The preferred method of treatment for uterine fibroids is
laparoscopic surgery. Non-cancerous tumour growth in the uterus is known as
uterine fibroids. Women who are capable of having children frequently develop
uterine fibroids. Uterine fibroids affect more than 21% of women worldwide.
Around the world, 30,000 myomectomies and 200,000
hysterectomies are performed annually. As a result, one of the key factors
boosting the laparoscopic
power morcellators market is the rise in uterine fibroid cases.
Uterine cancer occurs in roughly 28 out of every 100,000
women annually, and in the United States alone, 66,570 new cases were
identified in 2019. The adoption of laparoscopic hysterectomy, one of the
therapeutic options for early-stage uterine cancer, will drive the global
market for laparoscopic power morcellators higher as uterine cancer rates rise.
The FDA has released revised instructions for using the
product in surgical operations. The recommendations state that power
morcellators can be used in a small number of gynaecological procedures, such
as hysterectomies and myomectomies, but only on a limited number of patients
and when using tissue containment systems that have been commercially and
legally approved for use with laparoscopic power morcellators.
Comments
Post a Comment